Immunotherapy: Immunological bullets against Alzheimer's disease

Nature Reviews Drug Discovery

Volumn 12, Issue 1, 2013, Pages 24-

  Papatriantafyllou, Maria ^a  

^a Nature Reviews Immunology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN 23; INTERLEUKIN 23 RECEPTOR; PROTEIN ANTIBODY; PROTEIN P19; PROTEIN P35; PROTEIN P40; PROTEIN P40 ANTIBODY; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; CROHN DISEASE; DISEASE MODEL; DISEASE SEVERITY; DRUG RESPONSE; DRUG TARGETING; GENE EXPRESSION; GENE SILENCING; INNATE IMMUNITY; MICROGLIA; MULTIPLE SCLEROSIS; NONHUMAN; NOTE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; COGNITION; INTERLEUKIN-12; INTERLEUKIN-12 SUBUNIT P40; SIGNAL TRANSDUCTION;

EID: 84871878262     PISSN: 14741776     EISSN: 14741784     Source Type: Journal    
DOI: 10.1038/nrd3919     Document Type: Note

References (1)

1. vom Berg, J. et al. Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease-like pathology and cognitive decline. Nature Med. 25 Nov 2012 (doi:10.1038/nm.2965)